Showing results (51-60 of 89) with videos related to
Sort By:
Pageof 9
Toxicology|March 1, 1988
Prevention of diisopropylphosphorofluoridate (DFP)-induced skeletal muscle fiber lesions in ratG T Patterson, R C Gupta, K E Misulis, et al.The Journal of Pharmacology and Experimental Therapeutics|October 1, 1980
Presynaptic and postsynaptic neuromuscular effects of a specific inhibitor of acetylcholinesteraseR T Bois, R G Hummel, W D Dettbarn, et al.Biochemical Pharmacology|March 1, 1995
Hydrolysis of tetriso by an enzyme derived from Pseudomonas diminuta as a model for the detoxication of O-ethyl S-(2-diisopropylaminoethyl) methylphosphonothiolate (VX)F C Hoskin, J E Walker, W D Dettbarn, et al.Toxicology and Applied Pharmacology|July 1, 1987
Differences in central and peripheral neural actions between soman and diisopropyl fluorophosphate, organophosphorus inhibitors of acetylcholinesteraseK E Misulis, M E Clinton, W D Dettbarn, et al.Journal of Neurochemistry|August 1, 1993
Comparison between the effects of botulinum toxin-induced paralysis and denervation on molecular forms of acetylcholinesterase in musclesJ Sketelj, N Crne-Finderle, D Sket, et al.Addictive Behaviors|January 1, 1991
The relationship between cigarette smoking and chronic low back painR N Jamison, B A Stetson, W C ParrisOrthopaedic Review|December 1, 1988
Treatment outcome in low back pain patients: do compensation benefits make a difference?R N Jamison, D A Matt, W C ParrisJournal of Behavioral Medicine|April 1, 1988
Empirically derived Symptom Checklist 90 subgroups of chronic pain patients: a cluster analysisR N Jamison, D L Rock, W C ParrisJournal of Psychosomatic Research|January 1, 1988
Effects of time-limited vs unlimited compensation on pain behavior and treatment outcome in low back pain patientsR N Jamison, D A Matt, W C ParrisJournal of Psychosomatic Research|January 1, 1987
Use of sensory descriptors in assessing chronic pain patientsR N Jamison, J J Vasterling, W C ParrisPageof 9